Global Immunoglobulin Product Market by Type (IGA, IGD, IGE), ROA (IMIG, IVIG, SCIG), Application - Forecast 2024-2030- Product Image

Sale

Global Immunoglobulin Product Market by Type (IGA, IGD, IGE), ROA (IMIG, IVIG, SCIG), Application - Forecast 2024-2030

Report
190 Pages
March 2024
Region: Global
360iResearch™
ID: 4904902

UP TO €845EUR$875USD£723GBP OFF until Dec 31^st 2024

The Immunoglobulin Product Market size was estimated at USD 16.95 billion in 2023, USD 18.92 billion in 2024, and is expected to grow at a CAGR of 12.50% to reach USD 38.67 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Immunoglobulin Product Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Immunoglobulin Product Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Immunoglobulin Product Market, highlighting leading vendors and their innovative profiles. These include ADMA Biologics, Inc., Baxter International Inc., Bayer AG, Beckman Coulter, Inc., Bio Products Laboratory Ltd., Biotest AG, China Biologic Products Holdings, Inc., CSL Limited, Emergent BioSolutions Inc., Evolve Biologics Inc., F. Hoffmann-La Roche AG, GigaGen, Inc., Grifols, S.A., Horizon Therapeutics PLC, ImmunOs Therapeutics AG, Kamada Ltd., Kedrion S.p.A, Leadiant Biosciences, Inc., LFB S.A, Octapharma AG, Pfizer Inc., Sanquin Plasma Products B.V., and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Immunoglobulin Product Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- IGA
- IGD
- IGE
- IGG
- IGM
ROA
- IMIG
- IVIG
- SCIG
Application
- CIDP
- CLL
- Congenital AIDS
- Hypogammaglobulinemia
- Immunodeficiency Diseases
- ITP
- Kawasaki Disease
- Multifocal Motor Neuropathy
- Myasthenia Gravis

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Immunoglobulin Product Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Immunoglobulin Product Market?
What are the technology trends and regulatory frameworks in the Immunoglobulin Product Market?
What is the market share of the leading vendors in the Immunoglobulin Product Market?
Which modes and strategic moves are suitable for entering the Immunoglobulin Product Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Immunoglobulin Product Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the Cases of Immunodeficiency Diseases
5.1.1.2. Growing Geriatric Population Around the World
5.1.1.3. Surge in the Adoption of Immunoglobulin Products
5.1.2. Restraints
5.1.2.1. High Cost and Adverse Effects of the Immunoglobulin Products
5.1.3. Opportunities
5.1.3.1. Ongoing Research and Development Activities in the Immunoglobulin
5.1.3.2. Introduction of New & Advanced Immunoglobulin Products
5.1.4. Challenges
5.1.4.1. Strict Rules and Norms of Governing Bodies for Product Approval
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Immunoglobulin Product Market, by Type

6.1. Introduction
6.2. IGA
6.3. IGD
6.4. IGE
6.5. IGG
6.6. IGM

7. Immunoglobulin Product Market, by ROA

7.1. Introduction
7.2. IMIG
7.3. IVIG
7.4. SCIG

8. Immunoglobulin Product Market, by Application

8.1. Introduction
8.2. CIDP
8.3. CLL
8.4. Congenital AIDS
8.5. Hypogammaglobulinemia
8.6. Immunodeficiency Diseases
8.7. ITP
8.8. Kawasaki Disease
8.9. Multifocal Motor Neuropathy
8.10. Myasthenia Gravis

9. Americas Immunoglobulin Product Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Immunoglobulin Product Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Immunoglobulin Product Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. ADMA Biologics, Inc.
13.1.2. Baxter International Inc.
13.1.3. Bayer AG
13.1.4. Beckman Coulter, Inc.
13.1.5. Bio Products Laboratory Ltd.
13.1.6. Biotest AG
13.1.7. China Biologic Products Holdings, Inc.
13.1.8. CSL Limited
13.1.9. Emergent BioSolutions Inc.
13.1.10. Evolve Biologics Inc.
13.1.11. F. Hoffmann-La Roche AG
13.1.12. GigaGen, Inc.
13.1.13. Grifols, S.A.
13.1.14. Horizon Therapeutics PLC
13.1.15. ImmunOs Therapeutics AG
13.1.16. Kamada Ltd.
13.1.17. Kedrion S.p.A
13.1.18. Leadiant Biosciences, Inc.
13.1.19. LFB S.A
13.1.20. Octapharma AG
13.1.21. Pfizer Inc.
13.1.22. Sanquin Plasma Products B.V.
13.1.23. Takeda Pharmaceutical Company Limited
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. IMMUNOGLOBULIN PRODUCT MARKET RESEARCH PROCESS
FIGURE 2. IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2023 VS 2030
FIGURE 3. IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IMMUNOGLOBULIN PRODUCT MARKET DYNAMICS
FIGURE 7. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2023 VS 2030 (%)
FIGURE 10. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. IMMUNOGLOBULIN PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. IMMUNOGLOBULIN PRODUCT MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. IMMUNOGLOBULIN PRODUCT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGD, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGG, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGM, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 12. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMIG, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IVIG, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY SCIG, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CIDP, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CLL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CONGENITAL AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY HYPOGAMMAGLOBULINEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ITP, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY KAWASAKI DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MULTIFOCAL MOTOR NEUROPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. CANADA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 37. CANADA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. MEXICO IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. MEXICO IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 40. MEXICO IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. CHINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. CHINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 54. CHINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. INDIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. INDIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 57. INDIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. INDONESIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. INDONESIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 60. INDONESIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. JAPAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. JAPAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 63. JAPAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. MALAYSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. MALAYSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 66. MALAYSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. PHILIPPINES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. PHILIPPINES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 69. PHILIPPINES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. SINGAPORE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. SINGAPORE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 72. SINGAPORE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. SOUTH KOREA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. SOUTH KOREA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 75. SOUTH KOREA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. TAIWAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. TAIWAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 78. TAIWAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. THAILAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. THAILAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 81. THAILAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. VIETNAM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. VIETNAM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 84. VIETNAM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 89. DENMARK IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. DENMARK IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 91. DENMARK IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. EGYPT IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. EGYPT IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 94. EGYPT IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. FINLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. FINLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 97. FINLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. FRANCE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. FRANCE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 100. FRANCE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. GERMANY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. GERMANY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 103. GERMANY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. ISRAEL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. ISRAEL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 106. ISRAEL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. ITALY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. ITALY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 109. ITALY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NETHERLANDS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. NETHERLANDS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 112. NETHERLANDS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. NIGERIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. NIGERIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 115. NIGERIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. NORWAY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. NORWAY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 118. NORWAY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. POLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. POLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 121. POLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. QATAR IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. QATAR IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 124. QATAR IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SAUDI ARABIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. SAUDI ARABIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 130. SAUDI ARABIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SOUTH AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. SOUTH AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 133. SOUTH AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SPAIN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. SPAIN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 136. SPAIN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. SWEDEN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. SWEDEN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 139. SWEDEN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. SWITZERLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. SWITZERLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 142. SWITZERLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. TURKEY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. TURKEY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 145. TURKEY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. IMMUNOGLOBULIN PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 153. IMMUNOGLOBULIN PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 154. IMMUNOGLOBULIN PRODUCT MARKET LICENSE & PRICING

Companies Mentioned

ADMA Biologics, Inc.
Baxter International Inc.
Bayer AG
Beckman Coulter, Inc.
Bio Products Laboratory Ltd.
Biotest AG
China Biologic Products Holdings, Inc.
CSL Limited
Emergent BioSolutions Inc.
Evolve Biologics Inc.
F. Hoffmann-La Roche AG
GigaGen, Inc.
Grifols, S.A.
Horizon Therapeutics PLC
ImmunOs Therapeutics AG
Kamada Ltd.
Kedrion S.p.A
Leadiant Biosciences, Inc.
LFB S.A
Octapharma AG
Pfizer Inc.
Sanquin Plasma Products B.V.
Takeda Pharmaceutical Company Limited

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	190
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 18.92 Billion
Forecasted Market Value ( USD ) by 2030	$ 38.67 Billion
Compound Annual Growth Rate	12.5%
Regions Covered	Global
No. of Companies Mentioned	23

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3259EUR$3,374USD£2,789GBP €3621EUR$3,749USD£3,099GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4128EUR$4,274USD£3,533GBP €4587EUR$4,749USD£3,925GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4997EUR$5,174USD£4,276GBP €5552EUR$5,749USD£4,752GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5866EUR$6,074USD£5,020GBP €6518EUR$6,749USD£5,578GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7605EUR$7,874USD£6,508GBP €8450EUR$8,749USD£7,231GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Intravenous Immunoglobulin Market by Indication (Primary Immunodeficiency, Secondary Immunodeficiency), Form (Liquid IVIG, Lyophilized IVIG), End-User - Forecast 2024-2030

Global Subcutaneous Immunoglobulin Market by Indication (Primary Immunodeficiencies, Secondary Immunodeficiencies), End-User (Homecare Settings, Hospitals & Clinics) - Forecast 2024-2030

Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

Intravenous Immunoglobulin Global Market Report 2024

Intravenous Immunoglobulin (IVIg): Global Strategic Business Report